SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SB-2/A - Optional form for registration of securities to be sold to the public by small business issuers: [Amend]
SEC Accession No. 0000912057-97-009076
Filing Date
1997-03-17
Accepted
1997-03-17 00:00:00
Documents
16
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 SB-2/A SB-2/A 306253
2 EXHIBIT 1 EX-1 131368
3 EXHIBIT 10.4 EX-10.4 162391
4 EXHIBIT 10.5 EX-10.5 28045
5 EXHIBIT 10.7 EX-10.7 53541
6 EXHIBIT 10.8 EX-10.8 25006
7 EXHIBIT 10.9 EX-10.9 53834
8 EXHIBIT 10.10 EX-10.10 26860
9 EXHIBIT 10.11 EX-10.11 50569
10 EXHIBT 10.13 EX-10.13 3762
11 EXHIBIT 10.14 EX-10.14 3362
12 EXHIBIT 10.15 EX-10.15 72880
13 EXHIBIT 10.16 EX-10.16 57558
14 EXHIBIT 10.17 EX-10.17 27616
15 EXHIBIT 11 EX-11 1667
16 EXHIBIT 23.1 CONSENT OF RICHARD A. EISNER EX-23.1 473
  Complete submission text file 0000912057-97-009076.txt   1008033
Mailing Address ONE KENDALL SQUARE BUILDING 200 SUITE 2200 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200 SUITE 2200 CAMBRIDGE MA 02139 6176217154
APOLLO BIOPHARMACEUTICS INC (Filer) CIK: 0001029495 (see all company filings)

IRS No.: 043160456 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SB-2/A | Act: 33 | File No.: 333-18769 | Film No.: 97557887
SIC: 2834 Pharmaceutical Preparations